PhillipsE, KnowlesS, WeberE, ShearNH. Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. J Allergy Clin Immunol2000; 102:697–98.
3.
KontoleonP, IliasI, StavropoulosPG, PapapetrouPD. Urticaria after administration of alendronate. Acta Derm Venereol2000; 80:398.
4.
NaranjoCA, BustoU, SellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–45.
5.
EndoY, NakamuraM, KikuchiT. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo. Calcif Tissue Int1993; 52:248–54.
6.
FunayamaH, MayanagiH, TakadaH, EndoY. Elevation of histidine decarboxylase activity in the mandible of mice by Prevotella intermedia lipopolysaccharide and its augmentation by an aminobisphosphonate. Arch Oral Biol2000; 45:787–95.
7.
DengX, ZhiqianY, FunayamaH. Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immune-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate. Toxicol Appl Pharmacol2006; 213:64–73.
8.
RollaG, BuccaC, BrussinoL. Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma. Lancet1994; 343:426–7.
